Drugs / Carbon 11 Butanol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04050800 | Sep → Dec 2020 | neurodegenerative disease | Weill Medical College of Cornell University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbon 11 Butanol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04050800 ↗ |
| Modality | Diagnostic / imaging agent | “Two sequential administrations of a PET tracer” NCT04050800 ↗ |
| Route | Intravenous | “intravenous (IV) administration of 555 MBq of Carbon-11 butanol” NCT04050800 ↗ |